Pfizer in talks with China to market COVID-19 antiviral treatment: Report

China is reportedly in discussions with Pfizer to secure a license for the U.S. drugmaker’s COVID-19 antiviral Paxlovid amid a surge in cases in the mainland.

Read more…

Please follow and like us: